Gregory T. Lucier - 10 Oct 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Reporting relationship: Director
Issuer ticker: XRAY
Reported as of: 10 Oct 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Oct 2025, 16:44:10 UTC
Prior SEC filing: 07 Oct 2025
Next SEC filing: 09 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Jessica Nielsen Causey, Attorney-in-Fact for Gregory T. Lucier

Key filing fact

Gregory T. Lucier filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 15 Oct 2025.

Key facts

This page summarizes Gregory T. Lucier's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 15 Oct 2025, 16:44.

Change

Previous filing in this sequence was filed on 07 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001251299 Primary reporting owner

LUCIER GREGORY T

Relationship: Director
Address: C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE
Signature: /s/ Jessica Nielsen Causey, Attorney-in-Fact for Gregory T. Lucier
Signature date: 15 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XRAY transaction

Common Stock

Award

Transaction value: $0
Shares: +310
Change %: +1.3%
Price: $0.000000
Shares after: 24,357
Date: 10 Oct 2025
Ownership: By Family Partnership
Footnotes: F1

XRAY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 82,301
Date: 10 Oct 2025
Ownership: Direct

XRAY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 21,000
Date: 10 Oct 2025
Ownership: by Gregory Lucier IRA

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XRAY transaction Derivative

Stock Option (Right to Buy)

Gift

Transaction value: $0
Shares: -17,200
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 14 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,200
Exercise price: $12.96
Footnotes: F2, F3

XRAY transaction Derivative

Stock Option (Right to Buy)

Gift

Transaction value: $0
Shares: +17,200
Change %
Price: $0.000000
Shares after: 17,200
Date: 14 Oct 2025
Ownership: By Family Partnerhip
Underlying class: Common Stock
Underlying amount: 17,200
Exercise price: $12.96
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents dividends on restricted stock units (RSUs) awarded to the Family Partnership in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

Footnote F2

Stock Options vest in full one (1) year from date of grant.

Footnote F3

Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. The reporting person disclaims beneficial ownership of these NQSOs except to the extent of his pecuniary interest therein, and the inclusion of these NQSOs in this report shall not be an admission that the reporting person is the beneficial owner of the NQSOs for purposes of Section 16 of the Exchange Act or for any other purpose.